Drugstores say Medicare's $50 obesity drug program is catching on

The Bridge program, introduced on July 1, has quickly gained traction among Medicare beneficiaries, with drugstores like CVS and Walgreens reporting they've filled over 100,000 prescriptions for obesity drugs at a $50 monthly rate. This initiative underscores a significant shift in how Medicare addresses chronic health conditions, potentially reducing long-term healthcare costs. The program's rapid uptake highlights the growing recognition of obesity management as a critical component of preventative care, signaling a broader trend towards more comprehensive health strategies.